S&P 500 Futures
(0.26%) 5 104.50 points
Dow Jones Futures
(0.64%) 38 627 points
Nasdaq Futures
(0.53%) 17 743 points
Oil
(0.30%) $79.19
Gas
(0.15%) $2.04
Gold
(-0.02%) $2 309.20
Silver
(-0.07%) $26.81
Platinum
(1.09%) $973.10
USD/EUR
(-0.15%) $0.931
USD/NOK
(-0.53%) $10.93
USD/GBP
(-0.21%) $0.796
USD/RUB
(0.65%) $91.72

Aktualne aktualizacje dla Addex Therapeutics Ltd [ADXN.SW]

Giełda: SIX Branża: Pharmaceuticals, Biotechnology & Life Sciences
Ostatnio aktualizowano3 geg. 2024 @ 10:50

0.61% CHF 0.0660

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 10:50):

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland...

Stats
Dzisiejszy wolumen 273 751
Średni wolumen 1.18M
Kapitalizacja rynkowa 5.34M
EPS CHF-0.0339 ( 2023-09-30 )
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -0.440
ATR14 CHF0.00100 (1.52%)

Addex Therapeutics Ltd Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Addex Therapeutics Ltd Finanse

Annual 2022
Przychody: CHF1.42M
Zysk brutto: CHF-13.20M (-928.06 %)
EPS: CHF-0.470
FY 2022
Przychody: CHF1.42M
Zysk brutto: CHF-13.20M (-928.06 %)
EPS: CHF-0.470
FY 2021
Przychody: CHF2.92M
Zysk brutto: CHF0.00 (0.00 %)
EPS: CHF-0.450
FY 2020
Przychody: CHF3.61M
Zysk brutto: CHF0.00 (0.00 %)
EPS: CHF-0.480

Financial Reports:

No articles found.

Addex Therapeutics Ltd

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej